RecruitingNCT06691659

Next-Generation Photon-Counting CT Technology: Development and Clinical Evaluation


Sponsor

University of Pennsylvania

Enrollment

250 participants

Start Date

Nov 19, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This project aims to develop and evaluate a next-generation photon-counting CT prototype, and assess whether next-generation photon-counting CT--which enables reduced radiation dose, high spatial resolution, and spectral imaging--would facilitate improved diagnostic performance for abdominal, cardiothoracic, musculoskeletal, and neuroimaging.


Eligibility

Min Age: 18 YearsMax Age: 89 Years

Inclusion Criteria3

  • Age 18 to 89.
  • Participants must be informed of the investigational nature of this study and be willing to provide written informed consent and participate in this study in accordance with institutional and federal guidelines prior to study-specific procedures.
  • Not pregnant (based on attestation)

Exclusion Criteria3

  • Pregnant women will not be included. All females of childbearing potential must attest that they are not pregnant before CT imaging.
  • Participants with a known contrast allergy.
  • Any current medical condition, illness, or disorder, as assessed by medical record review and/or self-reported, that is considered by a physician investigator to be a condition that could compromise participant safety or successful participation in the study.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTCT-DACE

Photon Counting CT scan


Locations(1)

University of Pennsylvania - Center for Advanced Computed Tomography Imaging Services (CACTIS)

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06691659